Differential effects of response-contingent and response-independent nicotine in rats

European Journal of Pharmacology

Volumn 402, Issue 3, 2000, Pages 231-240

  Donny, Eric C ^a   Caggiula, Anthony R ^a,b   Rose, Christine ^a   Jacobs, Kimberly S ^a   Mielke, Michelle M ^a   Sved, Alan F ^a  

^a UNIVERSITY OF PITTSBURGH   (United States)

^b UNIVERSITY OF PITTSBURGH CANCER INSTITUTE   (United States)

Author keywords

Catecholamine; Corticosterone; Epinephrine; Nicotine; Norepinephrine; Self administration; Yoking

Indexed keywords

ADRENALIN; CORTICOSTERONE; NICOTINE; NORADRENALIN;

ADRENERGIC SYSTEM; ANIMAL BEHAVIOR; ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; CORTICOSTERONE BLOOD LEVEL; DOSE RESPONSE; DRUG EFFECT; DRUG SELF ADMINISTRATION; HYPOTHALAMUS HYPOPHYSIS ADRENAL SYSTEM; MALE; NONHUMAN; PRIORITY JOURNAL; RAT;

ANIMALS; CONDITIONING, OPERANT; CORTICOSTERONE; EPINEPHRINE; MALE; NICOTINE; NICOTINIC AGONISTS; NOREPINEPHRINE; RADIOIMMUNOASSAY; RATS; RATS, SPRAGUE-DAWLEY; REWARD; SELF ADMINISTRATION;

EID: 0034714269     PISSN: 00142999     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0014-2999(00)00532-X     Document Type: Article

References (48)

1. Andersson K., Siegal R., Fuxe K., Enroth P. Intravenous injections of nicotine induce very rapid and discrete reductions of hypothalamic catecholamine levels associated with increases of ACTH, vasopressin and prolactin secretion. Acta Physiol. Scand. 118:1983;35-40.
2. Benowitz N.L. Clinical pharmacology of nicotine. Annu. Rev. Med. 37:1986;21-32.
3. Benwell M.E.M., Balfour D.J.K. Effects of nicotine administration and its withdrawal on plasma corticosterone and brain 5-hydroxyindoles. Psychopharmacology. 63:1979;7-11.
4. Borysenko M., Borysenko J. Stress, behavior, and immunity: animal models and mediating mechanisms. Gen. Hosp. Psychiatry. 4:1982;59-67.
5. Caggiula A.R., Epstein L.H., Antelman S.M., Saylor S., Perkins K.A., Knopf S., Stiller R. Conditioned tolerance to the anorectic and corticosterone-elevating effects of nicotine. Pharmacol., Biochem. Behav. 40:1991;53-59.
6. Caggiula A.R., McAllister C.G., Epstein L.H., Antelman S.M., Knopf S., Saylor S., Perkins K.A. Nicotine suppresses the proliferative response of peripheral blood lymphocytes in rats. Drug Dev. Res. 26:1992;473-479.
7. Caggiula A.R., Epstein L.H., Antelman S.M., Saylor S., Knopf S., Perkins K.A., Stiller R. Acute stress or corticosterone administration reduce responsiveness to nicotine: implications for a mechanism of conditioned tolerance. Psychopharmacology. 111:1993;499-507.
8. Caggiula A.R., Epstein L.H., Antelman S.M., Knopf S., Perkins K.A., Saylor S., Donny E., Stiller R. Conditioned tolerance to nicotine in rats. Clarke P., Quik M., Thurau M., Adlkofer F. Effects of Nicotine on Biological Systems II. 1994;101-107 Birkhäuser, Basel.
9. Cam G.R., Bassett J.R. The effect of acute nicotine administration on plasma levels of thyroid hormones and corticosterone in the rat. Pharmacol., Biochem. Behav. 19:1983;559-561.
10. Cam G.R., Bassett J.R. Effect of prolonged exposure to nicotine and stress on the pituitary-adrenocortical response: the possibility of cross-adaptation. Pharmacol., Biochem. Behav. 20:1984;221-226.
11. Chiamulera C., Borgo C., Falchetto S., Valerio E., Tessari M. Nicotine reinstatement of nicotine self-administration after long-term extinction. Psychopharmacology. 127:1996;102-107.
12. Corrigall W.A., Coen K.M. Nicotine maintains robust self-administration in rats on a limited access schedule. Psychopharmacology. 99:1989;473-478.
13. Cryer P.E., Haymond M.W., Santiago J.V., Shah S.D. Norepinephrine and epinephrine release and adrenergic mediation of smoking-associated hemodynamic and metabolic events. N. Engl. J. Med. 295:1976;573-577.
14. DiCiano P., Blaha C.D., Phillips A.G. Changes in dopamine oxidation currents in the nucleus accumbens during unlimited access self-administration of D-amphetamine by rats. Behav. Pharmacol. 7:1996;714-729.
15. Donny E.C., Caggiula A.R., Knopf S., Brown C. Nicotine self-administration in rats. Psychopharmacology. 122:1995;390-394.
16. Donny E.C., Caggiula A.R., Mielke M.M., Jacobs K.S., Rose C., Sved A.F. Acquisition of nicotine self-administration in rats: the effects of dose, feeding schedule, and drug contingency. Psychopharmacology. 136:1998;83-90.
17. Donny E.C., Caggiula A.R., Mielke M.M., Booth S., Gharib M.A., Hoffman A., Maldovan V., Shupenko C., McCallum S.E. Nicotine self-administration in rats on a progressive ratio schedule of reinforcement. Psychopharmacology. 147:1999;135-142.
18. Dworkin S.I., Mirkis S., Smith G.E. Response-dependent versus response-independent presentation of cocaine: differences in the lethal effects of the drug. Psychopharmacology. 117:1995;262-266.
19. Fuxe K., Andersson K., Eneroth P., Harfstrand A., Agnati L.F. Neuroendocrine actions of nicotine and exposure to cigarette smoke: medical implications. Psychoneuroendocrinology. 14:1989;19-41.
20. Galica R., Pechnick R.N., Poland R.E., France C.P. Comparison of noncontingent versus contingent cocaine administration on plasma corticosterone levels in rats. Eur. J. Pharmacol. 387:2000;59-62.
21. Geng Y., Savage S.M., Razani-Boroujerdi S., Sopori M.L. Effects of nicotine on the immune response. J. Immunol. 156:1996;2384-2390.
22. Grunberg N.E., Popp K.A., Bowen D.J., Nespor S.M., Winders S.E., Eury S.E. Effects of chronic nicotine administration on insulin, glucose, epinephrine, and norephinephrine. Life Sci. 42:1988;161-170.
23. Kiritsy-Roy J.A., Mousa S.A., Appel N.M., Van Loon G.R. Tolerance to nicotine-induced sympathoadrenal stimulation and cross-tolerance to stress: differential central and peripheral mechanisms in rats. Neuropharmacology. 29:1990;579-589.
24. Kiyatkin E.A., Wise R.A., Gratton A. Drug- and behavior-associated changes in dopamine-related electrochemical signals during intravenous heroin self-administration in rats. Synapse. 14:1993;60-72.
25. Lakier J.B. Smoking and cardiovascular disease. Am. J. Med. 93:1992;8S-12S.
26. Matta S.G., Beyer H.S., McAllen K.M., Sharp B.M. Nicotine elevates rat plasma ACTH by a central mechanism. J. Pharmacol. Exp. Ther. 243:1987;217-226.
27. McAllister-Sistilli C.G., Caggiula A.R., Knopf S., Rose C.A., Miller A.L., Donny E.C. The effects of nicotine on the immune system. Psychoneuroendocrinology. 23:1998;175-187.
28. Mineka S., Henderson R.W. Controllability and predictability in acquired motivation. Annu. Rev. Psychol. 36:1985;495-529.
29. Moolton M., Kornetsky C. Oral self-administration of ethanol and not experimenter-administered ethanol facilitates rewarding electrical brain stimulation. Alcohol. 7:1990;221-225.
30. Morse D.E. Neuroendocrine responses to nicotine and stress: enhancement of peripheral stress responses by the administration of nicotine. Psychopharmacology. 98:1989;539-543.
31. Munck A., Guyre P.M., Holbrook N.J. Physiological functions of glucocorticoid in stress and their relation to pharmacological actions. Endocr. Rev. 5:1984;25-44.
32. Pauly J.R., Ullman E.A., Collins A.C. Adrenocortical hormone regulation of nicotine sensitivity in mice. Physiol. Behav. 44:1988;109-116.
33. Pauly J.R., Ullman E.A., Collins A.C. Chronic corticosterone administration modulates nicotine sensitivity and brain nicotinic receptor binding in C3H mice. Psychopharmacology. 101:1990;310-316.
34. Pauly J.R., Grun E.U., Collins A.C. Tolerance to nicotine following chronic treatment by injection: a potential role for corticosterone. Psychopharmacology. 108:1992;33-39.
35. Pich M.E., Pagliusi S.R., Tessari M., Talabot-Ayer D., Hooft van Huijsduijnen R., Chiamulera C. Common neural substrates for addictive properties of nicotine and cocaine. Science. 275:1997;83-86.
36. Pomerleau O.F., Pomerleau C.S. Research on stress and smoking: progress and problems. Br. J. Addict. 86:1991;599-603.
37. Robertson D., Tseng C., Appalsamy M. Smoking and mechanisms of cardiovascular control. Am. Heart. J. 115:1988;258-262.
38. Shoaib M., Schindler C.W., Goldberg S.R. Nicotine self-administration in rats: strain and nicotine pre-exposure effects on acquisition. Psychopharmacology. 129:1997;35-43.
39. Smith J.E., Co C., Freeman M.E., Lane J.D. Brain neurotransmitter turnover correlated with morphine-seeking behavior of rats. Pharmacol., Biochem. Behav. 16:1982;509-519.
40. Stalke J., Hader O., Hensen J., Bahr V., Scherer G., Oelkers W. Nicotine infusion in man stimulates plasma-vasopressin, -ACTH, and -cortisol, in a dose dependant manner. Adlkofer F., Thurau K. Effects of Nicotine on Biological Systems. 1994;339-343 Birkhäuser, Basel.
41. Sved A.F. PNMT-containing catecholaminergic neurons are not necessarily adrenergic. Brain Res. 481:1989;113-118.
42. Sved A.F., Fernstrom J. Tyrosine availability and dopamine synthesis in the striatum: studies with gamma-butyrolactone. Life Sci. 29:1981;743-748.
43. Swedberg M.D.B., Henningfield J.E., Goldberg S.R. Nicotine dependency: animal studies. Wonnocott S., Russell M.A.H., Stolerman I.P. Nicotine psychopharmacology: molecular, cellular and behavioral aspects. 1990;38-76 Oxford Univ. Press, New York.
44. Tessari M., Valerio E., Chiamulera C., Beardsley P.M. Nicotine reinforcement in rats with histories of cocaine self-administration. Psychopharmacology. 121:1995;282-283.
45. Valentine J.D., Hokanson J.S., Matta S.G., Sharp B.M. Nicotine self-administration in rats having unlimited access to the drug. Psychopharmacology. 133:1997;300-304.
46. Van Loon G.R., Kiritsy-Roy J.A., Brown L.V., Bobbitt F.A. Nicotine regulation of sympathoadrenal catecholamine secretion: cross-tolerance to stress. Martin W.R., Van Loon G.R., Iwamoto E.T., Davis L. Tobacco Smoking and Nicotine. 1987;263-276 Plenum, New York.
47. Volle R.L, Koelle G.B. Ganglionic stimulating and blocking agents. Goodman L.S., Gilman A. The Pharmacological Basis of Therapeutics. 1975;565-577 Macmillan, New York.
48. Westfall T.C., Watts D.T. Catecholamine excretion in smokers and nonsmokers. J. Appl. Physiol. 19:1963;40-42.